跳至主要内容
临床试验/NCT04930952
NCT04930952已完成不适用

Complications of Ethanol-amine Oleate Intralesional Sclerotherapy Injections of Maxillofacial Venous Malformations in Pediatric Patients

Suez Canal University1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2019年2月28日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
15
试验地点
1
主要终点
Clinical Response

研究概览

简要总结

The aim of this study is to clarify complications of Ethanolamine Oleate intralesional injections of maxillofacial venous formations in pediatric patients

详细描述

Maxillofacial Venous malformations cause many functional and esthetic complications in children, intralesional sclerotherapy is the best choice of treatment; and Ethanol-amine Oleate has been the most commonly used sclerosing agent.

The aim of this study is to clarify complications of Ethanolamine Oleate intralesional injections of maxillofacial venous formations

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

年龄范围
— 至 12 Years(Child)
性别
All
接受健康志愿者

入选标准

  • maxillofacial venous malformation

排除标准

  • Patients with lung, liver, or kidney diseases
  • Patients with Klippel-Trenaunay syndrome
  • Patients mental or physical disabilities

结局指标

主要结局

Clinical Response

时间窗: 12 months

Complete Response - Marked Improvement - Moderate Improvement - No Response

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sarah Arafat

Assistant Lecturer

Suez Canal University

研究点 (1)

Loading locations...

相似试验